Therefore, as suggested by Shields et al. [4], completing the diagnostic investigation by measuring C-peptide and the main islet autoantibodies can be useful in distinguishing between MODY and T1DM, particularly in patients with an early diagnosis who are thin and have been in use of insulin therapy since diagnosis. The gene discussed is INS; the disease is MODY.